NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
Clinical Trials
23 trialsNCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT04034095 2025-12-15
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Completed
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT02366494 2024-11-25
Micro RNAs to Predict Response to Androgen Deprivation Therapy
Medical College of Wisconsin
Completed
NCT03328364 2024-11-21
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
Astellas Pharma Inc
Completed
NCT06498921 2024-10-24
BELBEQA
Bayer
Completed
NCT02154490 2023-06-01
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
SWOG Cancer Research Network
Completed
NCT05471427 2022-07-22
ANCHISES
Azienda Ospedaliero-Universitaria Careggi
Completed
NCT02376296 2022-02-17
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Saladax Biomedical, Inc.
Completed
NCT01160705 2020-11-17
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
Cancer Trials Ireland
Completed
NCT03419442 2020-10-22
Multi-academic Center Study of Xofigo Patients
Bayer
Completed
NCT02575547 2020-07-30
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Sun Yat-sen University
Completed
NCT00755313 2017-11-24
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco
Completed
NCT00392938 2017-03-13
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
University of Washington
Completed
NCT02479217 2017-02-17
Safety of Xeloda in Solid Tumours
Hoffmann-La Roche
Completed
NCT02972216 2016-11-23
Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
Yung Shin Pharm. Ind. Co., Ltd.
Completed
NCT01777945 2016-08-19
XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Completed
NCT01251653 2016-05-30
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel
Boehringer Ingelheim
Completed
NCT00418704 2013-10-01
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Groupe Francais De Pneumo-Cancerologie
Completed
NCT00213694 2013-03-05
PROSTACOX : Metastatic Prostate Chemotherapy
University Hospital, Rouen
Completed
NCT00452985 2012-08-14
OCSTUD
Sanofi
Completed
NCT01110291 2010-04-27
Docetaxel
University of Turku
Completed